Arkolith/Insider Trading/MBRX/Form 4

Klemp Walter V

CEO and President, DirectorMoleculin Biotech, Inc. (MBRX) · full profile →Form 4 · filed Nov 6, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 4, 2024Grant(A)100K——213K
Nov 4, 2024Grant(A)115K——328K
Oct 25, 2024Grant(A)44K——372K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-033703) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML